Source: India Infoline

Nesher: Zydus Nesher Pharmaceuticals receives final approval from USFDA

Cadila Healthcare is currently trading up by 2.78% as Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from USFDA

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100